MICAH HON-SEN YU
SAN BERNARDINO, CA
Browse related groups: CA GlaxoSmithKline, LLC. All categories
This page merges CMS profile IDs: 5701388, 7233283 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$36,961.68
- Category: General Payments
- Program years: PY2018–2024
- Record count: 114
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $31,925.16 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $31,815.00 | 4 |
| Food and Beverage | $110.16 | 5 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $29,268.54 | 2 |
| UCB, Inc. | $2,605.10 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $31.91 | 1 |
| Exact Sciences Corporation | $19.61 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087424882 | Novartis Pharmaceuticals Corporation | $31.91 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114957235 | Exact Sciences Corporation | $19.61 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116224972 | GlaxoSmithKline, LLC. | $29,250.00 | 01/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1116293065 | GlaxoSmithKline, LLC. | $18.54 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143319676 | UCB, Inc. | $570.00 | 01/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1143319680 | UCB, Inc. | $570.00 | 01/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1143319684 | UCB, Inc. | $1,425.00 | 01/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1143319689 | UCB, Inc. | $24.62 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143319693 | UCB, Inc. | $15.48 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 5701388, 7233283
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.